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ABSTRACT: The mechanism by which stimulated polymorphonuclear leukocytes
and neutrophils (PMNs) damage pulmonary vascular endothelium was investigated.
The authors assessed the ability of unstimulated and mechanically stimulated
PMNs to adhere to pulmonary endothelial cells and, thereby, alter pulmonary vas-
cular permeability, measured as the pulmonary filtration coefficient (K) and haemo-
dynamics. PMNs were stimulated by gentle agitation in a glass vial for 10 s.
Perfusing lungs with the stimulated PMNs (n=6) resulted in significant accumula-
tion of PMNs within the lungs, assessed by myeloperoxidase levels, and elicited a 4-
fold increase in K and a 2-fold increase in pulmonary vascular resistance as compared
to lungs perfused with unstimulated cells (n=6). The increases in K were completely
blocked by GF109203X, a protein kinase C inhibitor (n=6); however, GF109203X only
partially attenuated the increase in vascular resistance and had little effect on the
accumulation of stimulated PMNs. An agonist of protein kinase C, phorbol myristate
acetate, elicited dose dependent increases in both K and pulmonary vascular resis-
tance even in the absence of PMNs (n=6).
These findings indicate that the increases in pulmonary filtration coefficient and
pulmonary vascular resistance induced by polymorphonuclear neutrophils result
from endothelial cell injury mediated by activation of protein kinase C within the
endothelial cells themselves.
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Acute respiratory distress syndrome (ARDS) is thought
to be typical of pulmonary inflammation and involving
activation of polymorphonuclear leukocytes and neutro-
phils (PMNs) [1]. In addition, it is known that PMNs are
activated during cardiopulmonary bypass [2], and there-
fore, they may play a role in the pulmonary injury asso-
ciated with the procedure [3, 4]. It was postulated that
during bypass, mechanical shear stress stimulates PMNs
to increase the availability of adhesion molecules on their
surfaces. Consistent with this notion, mechanical agita-
tion for 30 s on a tube mixer induced an increase in the
proportion of PMNs bearing receptors for C3b (C3b-R),
now classified as CD 11b/CD 18 (Mac 1) [5], thus enab-
ling them to adhere more readily to vascular endothelial
cells. Once bound, PMNs probably injure endothelial
cells and increase pulmonary vascular resistance by rel-
easing chemical mediators such as leukotrienes, oxygen
radicals and/or elastase.
Alternatively or additionally, the endothelial cell injury
caused by stimulated PMNs may result from an interaction
between polymorphonuclear adhesion molecules and an
endothelial cell signalling pathway mediating conversion
of xanthine dehydrogenase (XD) to xanthine oxidase (XO)
[6], in heart and lung, XO is only present in the endo-
thelial cells lining the affected vasculature [7]. Increased
endothelial XO would be expected to elevate intracellular
levels of cytotoxic superoxide anions (O2
-), which would
in turn result in endothelial cell damage and increased
pulmonary vascular permeability. On the other hand,
recent reports indicate that activation of protein kinase
(PK)C results in cytoskeletal protein phosphorylation in
pulmonary arterial cell monolayer, and then results in
endothelial cell contraction and resultant barrier dysfunc-
tion [8, 9]. In this study, the authors addressed the
question of whether stimulated PMNs increase pulmon-
ary vascular permeability and/or resistance and, if so,
whether PKC-mediated intracellular signal transduction
is involved in the process.
Materials and methods
Isolation of polymorphonuclear leukocytes and neutro-
phils
Human PMNs were isolated from heparinized blood
obtained from a healthy adult who had no infectious foci
and was taking no anti-inflammatory medications. Blood
samples were layered over Polymorphprep (Nycomed
Pharma., OSIO, Norway), centrifuged at 5006g for 35
min at room temperature, and the resultant band of PMNs
was harvested using a Pasteur pipette. The PMN fraction
was resuspended in modified Hanks' balanced salt solution
(HBSS; Sigma, St. Louis, MO, USA) lacking calcium,
magnesium and bicarbonate, and centrifuged again at
4006g for 10 min. The cells were finally resuspended in
Eur Respir J 2000; 15: 452±458
Printed in UK ± all rights reserved
Copyright #ERS Journals Ltd 2000
European Respiratory Journal
ISSN 0903-1936
HBSS in order to restore normal osmolarity and then
counted using an automated cell counter (Courter T-890;
Coulter Electronics Inc., Tokyo, Japan).
Isolated rat lung preparation
Twenty-four adult male Sprague-Dawley rats (248.6
32.1 g) were used in this study. Each animal was anes-
thetized with pentobarbital sodium (50 mg.kg, i.p.); a
tracheotomy was then performed, and a 15-gauge luer stub
adapter (Clay Adams, Parsippany, NJ, USA) was inserted
into the trachea. The carotid artery was then catheterized
(PE 50; Clay Adams), 500 units.kg-1 of heparin was in-
jected, and the rats were exsanguinated. At that point, the
authors made a sternum-splitting incision and opened the
pericardium. The pulmonary artery was catheterized by
way of the right ventricle using polyethylene tubing (PE
200; Clay Adams) connected to silastic tubing (outside
diameter (OD) 4.65 mm, inside diameter (ID) 3.35 mm; Dow
Corning, Midland, MI, USA). The aorta was ligated, and
the left ventricle catheterized. The authors then flushed the
lungs with 50 ml of saline until the effluent was clear, and
the lungs had turned white. The venae cavae were then
ligated, and the heart and lungs were removed en bloc.
After recording the weight of the preparation, which
included the heart, lungs and catheters, it was placed in a
Plexiglas box (B-345; Lustro Ware, Tokyo, Japan) where it
was suspended from a counterbalancing bar attached to a
force displacement strain gauge transducer (FT pick up
TB-61 1T; Nihon Kohden, Tokyo, Japan). The trachea was
connected to a compressed-air source so that the airway
pressure could be continuously maintained at 2.0 cmH2O.
The pulmonary arterial and left ventricular catheters were
connected to arterial and venous reservoirs, respectively.
The reservoirs were immersed in a water bath and warmed
to 378C, saturated with mixed gas containing 30% O2, 5%
CO2, and 65% N2 and could be individually set at various
heights to yield desired vascular pressures.
The lungs were kept in an isogravimetric state under
zone 3 conditions (pulmonary arterial pressure > pulmon-
ary venous pressure > alveolar pressure). The heart and
lungs were perfused with Krebs-Henseleit buffer contain-
ing 6% bovine serum albumin (fraction V, Sigma), and a
constant pressure-flow system was used throughout the
experiments. Pulmonary venous and airway pressures
(PPV and Paw, respectively) were adjusted to 2.5 and 2.0
cmH2O, respectively, and pulmonary arterial pressure
(Ppa) was adjusted so that the lungs were neither gaining
nor losing weight.
Experimental protocol
The objective of these experimental protocols was to
determine whether stimulated PMNs increase pulmonary
vascular permeability and resistance and, if so, whether
PKC mediates the effect. To accomplish this, four series of
experiments were carried out in four groups of isolated rat
lungs. In the first series (unstimulated group; n=6), 125 mL
of saline was injected into the pulmonary artery; ~30 min
later, unstimulated PMNs were injected. In the second
series (stimulated group, n=6), 125 mL of Dimethyl Sulf-
oxide (DMSO; Sigma), the vehicle for GF109203X (Sig-
ma), an inhibitor of PKC, was injected; ~30 min later, the
perfusate was changed to control saline in order to avoid
affecting the PMNs, and stimulated PMNs were injected.
The third series (GF group, n=6) was identical to the se-
cond except that 5 mM GF109203X was added to the
DMSO vehicle. To directly assess the extent to which
activation of PKC in endothelial cells increases the filtra-
tion coefficient, in the fourth series of experiments (phor-
bol myristate acetate (PMA) group; n=6), either 20 or 200
nM PMA (Sigma), a PKC agonist, was injected into the
pulmonary artery.
The pulmonary filtration coefficient (K) was measured
before and after each injection of vehicle and again 90 min
after injection of the PMNs, the authors measured (K), an
indicator of vascular permeability. To calculate pulmonary
vascular resistance, perfusate flow rate (Q'p), Ppa and
double occlusion pressure (Pdo), which reflects pulmonary
capillary pressure [10], were all measured. As mentioned
above, Ppv was set at 2.5 cmH2O. Once these measure-
ments had been obtained, the lungs were perfused with
either stimulated or unstimulated PMNs at a final con-
centration of 250 cells.mL-1 of perfusate (except PMA
group) for ~10 min. The lungs were then flushed with 50
mL of saline to washout intravascular PMNs that had not
adhered to endothelial cells and then stored (except PMA
group) at -808C until myeloperoxidase (MPO) measure-
ments were made.
Stimulation of PMNs was achieved by shaking them
gently in a glass vial for 10 s at room temperature (20
28C). The PMN specimens were made up of 83.36.3%
neutrophils; the remaining cells were monocytes.
Measurements
Ppa, Ppv and Paw were continuously measured with
pressure transducers (P23ID; Gould Inc., Santa Ana, CA,
USA), and Q'p was monitored using an electromagnetic
flow meter (FF050 and MF-27; Nihon Kohden); these four
parameters as well as lung weight were all continuously
recorded on a polygraph (WT-687G; Nihon Kohden).
Calculation of the pulmonary filtration coefficient
K was calculated as previously described [11]. Briefly,
arterial and venous pressures were simultaneously in-
creased by 3 cmH2O and the time-dependent increase in
lung weight, which occurred in two phases, was mea-
sured. The standard interpretation of the weight gain
curve is that there is an early gain due to increased vas-
cular volume and slower gain resulting from continuous
filtration. The increases in vascular volume were com-
plete within 3 min; consequently, this component could
be discriminated from the filtration component by plot-
ting the log of the weight gain as a function of time [11,
12]. By using the method of least squares to fit a line to
the later phase (data obtained from the last 7 min) and
extrapolating back to time zero, the authors obtained the
initial filtration rate. K was calculated by dividing the
initial filtration rate by the applied microvascular pressure
increment and normalizing to 1 g of wet lung weight.
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Calculation of the pulmonary vascular resistances
The pulmonary arterial and venous resistances (Ra, Rv)
and the pulmonary arterial and venous resistance ratio (Ra/
Rv) were calculated as follows:
Ra  PpaÿPdo=Q'p 1
Rv  PdoÿPpv=Q'p 2
Ra=Rv  PpaÿPdo=PdoÿPpv 3
Myeloperoxidase assay
As an index of PMN accumulation in the lungs, MPO
was measured using a luminescence technique. The frozen
rat lungs were thawed, a volume of 0.02% cethyltrimethyl
ammonium bromide (CTAB; Wako Chemicals, Tokyo,
Japan) equivalent to five times the lung weight was added,
and the lungs were homogenized at 08C. The homogenates
were centrifuged at 12,000 6g and 48C for 15 min in a
high speed, refrigerated centrifuge (HITACHI 18PR-3;
Hitachi, Tokyo, Japan). The pellets were rapidly frozen in
liquid nitrogen, placed on ice, and then homogenized by
sonication (UD201; Tomy Seiki, Tokyo, Japan) at 30 W
for 30 s (30 times of 0.5 s burst plus 0.5 s stand). Freezing
and sonication of the pellets were repeated seven times.
The homogenates were centrifuged at 16,0006g and 48C
for 15 min, and the supernatants were collected for assay.
Initially, standard reagent (50 mM superoxide dismutase
(SOD), 20 mL; 2 mM desferrioxamine, 20 mL; 50 mM
KBr, 20 mL; 40 mM H2O2 25 mL; 0.2 M acetate-buffer, 1
mL; distilled water, 765 mL; and 0.2 mM 2-methyl-6-
[p methoxyphenyl]-3, 7-dihydroimidazo[1,2-a] pyrazin-3-
one (MCLA; Tokyo Kasei Organic Chemicals, Tokyo,
Japan], 100 mL) was injected into a luminescence reader
(BLR301; Aloca, Tokyo, Japan), and the basal lumines-
cence was characterized for 3 min. The luminescences of
the test specimens (50 mL of supernatant) were then ass-
ayed.
Statistical analysis
Data are expressed as meanSD and were analysed by
analysis of variance (ANOVA). Probability (p) values
of<0.05 were accepted as significant.
Results
Pulmonary vascular permeability
Addition of vehicle or unstimulated PMNs had no
significant effect on baseline values of K (table 1). On the
other hand, after stimulated PMNs were injected, there
was a 4-fold increase in K, suggesting that significant
injury to the endothelium had occurred. The increase in K
induced by stimulated PMNs was completely blocked by
pretreatment with GF 109203X (fig. 1, table 1). In the
PMA group, K was unaffected by the low dose of PMA
(20 nM), but at the higher concentration (200 nM), PMA
elicited a significant increase in K in the absence of
PMNs (fig. 2, table 1).
Pulmonary vascular resistance
Ppa and Pdo were not significantly affected by any of the
treatment protocols (table 2). However, upon injection of
stimulated PMNs, there was a significant increase in
pulmonary vascular resistance (Ra, Rv and total vascular
resistance (Rt)) and a concomitant decrease in Q'p; effects
that were completely blocked by GF 109203X-induced
blockade of PKC. Conversely, activation of PKC by
PMA dose dependently increased Ra, Rv and Rt and de-
creased Qp.
Myeloperoxidase assay
The MPO levels measured following injection of stimu-
lated PMNs (44.8224.53 Kcpm) were significantly higher
than those seen following injection of unstimulated PMNs
(5.866.73 Kcpm; fig. 3). Thus, it appears that stimulated
PMNs accumulated in the lungs to significantly greater
extent than unstimulated cells. When the correlation be-
tween vascular permeability and PMN accumulation was
analysed in the groups injected with either unstimulated
or stimulated PMNs, a significant association between K
and MPO levels was found (fig. 4). The accumulation of
PMNs was apparently not PKC-dependent since MPO
level in the presence of GF109203X (31.9311.98 Kcpm)
remained significantly higher than in the unstimulated
groups and were not significantly different from the sti-
mulated group.
Table 1. ± Effect of experimental protocols on the pul-
monary filtration coefficient (K)
K mg.cmH2O
-1.min-1.g-1
Treatment Baseline Vehicle Experiment
Unstimulated PMNs 4.971.14 4.450.87 4.453.23
Stimulated PMNs 5.880.55 5.551.51 23.5212.82*,{
Stimulated PMNs +
GF 109203X
4.481.69 4.411.79 4.901.46
200 nM PMA (no
cells)
5.152.16 5.071.78 13.366.90**
Values are expressed as meanSD. PMNs: polymorphonuclear
leukocytes; PMA: phorbol myristate acetate. *: p<0.05 versus
baseline of stimulated group; {: p<0.05 versus value after
injection of PMNs (Experiment) in the unstimulated group; **:
p<0.05 versus baseline and low dose PMA (not shown).
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Fig. 1. ± Effects of the protein kinase C inhibitor GF109203X (GF), on
the increase in pulmonary vascular permeability (filtration coefficient)
elicited by stimulated polymorphnuclear leukocytes and neutrophils
(PMNs). Values are shown as meanSD. {: p<0.05 versus unstimulated
PMNs group.
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Discussion
Little information is currently available on the mech-
anism by which stimulated PMNs evoke increases in
pulmonary vascular permeability. It was found that stimu-
lated PMNs significantly increased pulmonary vascular
permeability after first adhering to the endothelial cells
lining the pulmonary arteries. Consistent with this idea,
CD 11b/CD18 (Mac 1) on the surfaces of PMNs were up-
regulated by mechanical stimulation [5], these b2 leukocy-
te integrins are glycoprotein-derived adhesion molecules
that enable PMNs to attach firmly to endothelial cells.
PMN-induced increases in vascular permeability were
blocked when stimulated PMNs were treated with anti-
CD 18 monoclonal antibodies [5].
It was found that GF109203X, a PKC antagonist, block-
ed the PMN-induced increase in the vascular permeability,
whereas PMA, a PKC agonist, increased vascular perme-
ability even in the absence of PMNs. The dependence on
PKC activation indicates that one or more intracellular
signal transduction pathways must be involved. Vascular
permeability has also been shown to be increased by super-
oxide anions, and the effect was blocked by allopurinol, a
XO inhibitor [13±15]. It is postulate, therefore, that in
heart and lung, the endothelial cell injury caused by
stimulated PMNs results largely from an interaction be-
tween PMN adhesion molecules and an endothelial cell
signalling pathway mediating conversion of XD to XO
[6]. ln that regard, XO is only present in endothelial cell
lining affected vasculature [7].
Intercellular adhesion molecule (ICAM)-1 is a member
of the immunoglobulin superfamily; it has five immuno-
globulin-like domains and is constitutively expressed on
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Fig. 3. ± Myeloperoxidase (MPO) measured after injection of polymor-
phonuclear leukocytes and neutrophils (PMNs). MPO levels were higher
in lungs injected with stimulated PMNs than in lungs injected with
unstimulated PMNs. GF109203X (GF), a protein kinase C inhibitor, did
not affect the elevated MPO levels induced by stimulating PMNs. {:
p<0.05 versus unstimulated PMNs group.
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Fig. 2. ± Effects of the protein kinase C agonist phorbol myristate ace-
tate (PMA), on the increase in pulmonary vascular permeability (fil-
tration coefficient). Final concentrations of low and high dose PMAwere
20 and 200 nM, respectively. Values are expressed as meanSD. *: p<
0.05 versus baseline.
Table 2. ± Effect of experimental protocols on selected haemodynamic parameters
Ppa
cmH2O
Pdo
cmH2O
Q'p
mL.min-1
Ra cmH2O
.mL-1.min-1
Rv cmH2O
.mL-1.min-1
Rt cmH2O
.mL-1.min-1
Ra/Rv
Unstimulated PMNs
baseline 11.41.1 6.10.5 14.84.7 0.390.13 0.270.12 0.660.24 1.530.50
vehicle 11.21.3 5.90.5 15.04.6 0.370.13 0.250.09 0.620.20 1.560.51
experiment 11.21.4 6.40.8 14.75.5 0.350.11 0.300.15 0.660.25 1.260.38
Stimulated PMNs
baseline 9.90.7 5.30.5 11.34.1 0.440.14 0.300.18 0.740.30 1.710.65
vehicle 10.00.8 5.50.3 7.72.0 0.610.13 0.410.09 1.020.21 1.480.11
experiment 9.80.6 5.50.3 3.81.2** 1.210.38**,## 0.890.38**,# 2.090.75**,## 1.420.21
Stimulated PMNs +
GF109203X pretreatment
baseline 10.71.5 5.20.7 11.03.0 0.550.24 0.250.07 0.800.27 2.251.18
vehicle 11.11.1 6.00.5 8.72.1 0.600.15 0.420.12 1.030.24 1.490.46
experiment 11.10.8 6.40.8 7.31.6 0.680.27 0.560.18 1.240.42 1.230.31
PMA stimulation without
PMNs
baseline 9.80.9 5.10.5 10.01.4 0.490.21 0.260.05 0.750.20 1.971.01
low dose 9.91.0 5.80.7 6.81.6* 0.620.18 0.500.14 1.120.24 1.320.49
high dose 10.11.2 5.21.0 3.31.4*,{ 1.981.41*,{ 1.110.64*,{ 3.091.80*,{ 2.040.90
Values are expressed as meanSD. Ppa and Pdo: pulmonary arterial and double occlusion pressures, Q'p: perfusate flow rate; Ra, Rv and
Rt: pulmonary arterial, venous and total vascular resistances; PMNs: polymorphonuclear leukocytes; PMA: phorbol myristate acetate.
*: p<0.05 versus baseline; **: p<0.01 versus baseline; #: p<0.05 versus vehicle; ##: p<0.01 versus vehicle; {: p<0.05 versus low dose (20
nM) group.
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endothelial cells [16]. By interacting with ICAM-1 and
leukocyte function associated antigen (LFA)-1 on the sur-
face of endothelial cells, attached PMNs induce conver-
sion of XD to XO [6, 17], and the resultant generation of
superoxide anion might be damaging to the endothelial
cells.
Cytokines, including interleukin (IL)-1, tumour necrosis
factor (TNF)-a and interferon (IFN)-c, upregulate ICAM-1
on the surface of endothelial cells; signals arising from IL-1
or TNF-a act at the nucleus inducing transcription and ex-
pression of ICAM-1 messenger ribonucleic acid (mRNA)
[18]. Analogously, PMA-stimulated CD4+ T-lympho-
cytes induce ICAM-1 expression [19], suggesting T-cells
may act via a similar pathway. In a B-cell lymphoma line,
the interaction of ICAM-1 and LFA-1 elicit tyrosine hyper-
phosphorylation of a number of proteins including p53/
p56lyn kinase [20]. Lyn kinase has been detected in various
haematopoietic cells, including B-cells [21], neutrophils
[22], and eosinophils [23] and once phosphorylated may
act as a cytoplasmic protein tyrosine (PTK). Another pos-
sible PTK is p60src which has been detected in a rat cerebral
microvessel endothelial cell line [24].
Activated PTK in turn activates phospholipase C (PLC)
which hydrolyzes phosphatidylinositol 1,4,5 trisphosphate
forming inositol 1,4,5 trisphosphate (IP3) and 1, 2-dia-
cylglycerol (DAG), second messengers that respectively
increase intracellular Ca2+ concentration and activate PKC.
The PKC activation would be expected to result in increa-
sed conversion of XD to XO, phosphorylation of myosin
light chain and actin rearrangement [25]. Conversely,
inhibition of PTK blocks both upregulation of ICAM-1
by IL-1 or TNF-a, [26] and conversion of XD to XO [17].
Recently, CARDEN et al. [27] reported that intestinal
ischaemia reperfusion activated circulating neutrophils
to promote elastase-mediated lung injury. Neutrophil el-
astases, proteases and thrombin are a family of serine
protease. When activated, neutrophils release several pro-
teases, especially serine protease elastase. They have
traditionally been considered to participate principally in
the degradation of extracellular proteins [28]. However,
they are also signalling molecules that regulate multiple
cellular functions by activating specific receptors [29].
Besides thrombin, trypsin, plasmin, granzyme A, and
cath-epsin G activate proteinase activated receptor
(PAR)-1 [30, 31]. PAR-1, a member of G-protein-coupled
rec-eptors (GPCRs), couples to several different G-
proteins [29]. The principal mechanism is through Gaq
proteins, resulting PLC, phosphatidyl inositol 1,4,5
trisphosphate hydrolysis. Formation of IP3 and DAG
activate PKC.
It was observed that PMA elicited a concentration dep-
endent increase in the pulmonary vascular permeability,
confirming the involvement of endothelial PKC in the
response. Pdo, which reflects pulmonary capillary pressure
[10], was unaffected by any of the experimental proto-
cols, indicating that the increases in K elicited by ac-
tivated PMNs and PMA were in fact due to changes in
pulmonary vascular permeability (i.e. nonhaemodynamic
oedema). It is known that PKC has important functions in
the regulation of endothelial permeability and in the
maintenance of endothelial integrity [32]. For instance,
PKC phosphorylates cytoskeletal proteins in cultured bov-
ine pulmonary artery endothelial cells resulting in barrier
dysfunction [8]. GARCIA et al. [33] indicated that endo-
thelial cell contraction, gap formation and barrier dys-
function occur via myosin light chain kinase (MLCK)
dependent and independent mechanisms and are modu-
lated by both PKC and cyclic adenosine monophosphate
(cAMP)-dependent protein kinase A activities. In the cur-
rent experiments, the concentration of PMAwas relatively
high, therefore, some other kinases, such as protein kinase
A, might be involved in the mechanisms of the increase in
K. So far, little information is available on the mechanisms
by which activation of PKC and/or other kinases evoke
barrier dysfunction of endothelial cells. There are several
possibilities that induce dysfunction of endothelial cells by
activation of PKC including; conversion of XO to XD [6,
17] that induces generation of superoxide anions [13±15];
and activation of MLCK that induces actin rearrangement
[25]. Recent reports indicate that endothelial MLCK regu-
lates neutrophils migration [34, 35]. It is speculated that
PMNs adhesion to the endothelial cells induces; activation
of an intracellular signal transduction system in endothelial
cells and finally leads to gap formation of endothelial cells,
and neutrophil migration through the gap [36].
PKC-induced contraction of pulmonary vascular smo-oth
muscle was probably responsible for the concentration dep-
endent increases in Ra and Rv and the decrease in Q'p elicited
by PMA. Usually contraction of the pulmonary vessels de-
creases vascular surface area and, therefore, filtration. This
means that vascular permeability may have been underest-
imated in the present study. Injection of stimulated PMNs
increased vascular resistance in both the stimulated group
and in the GF group where activation of PKC was blocked,
although the effect was only statistically significant in the
former. Thus, stimulated PMNs probably increased vascular
resistance in two ways: they occluded capillaries by adher-
ing to their walls [37] and they elicited PKC activation
leading to vascular smooth muscle contraction.
In the present study, effects on endothelium were not
isolated from those on vascular smooth muscle. To address
that question, examinations using cell culture systems will
be necessary.
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Fig. 4. ± For each experimental group, pulmonary vascular filtration
coefficients are plotted as a function of the myeloperoxidase (MPO)
level. Each point represents a single experiment. The regression line was
calculated using the data obtained from the stimulated (*) and unstim-
ulated (s) groups (n=12; r=0.62, p<0.05). The data from the protein
kinase C inhibitor FG109203X (GF) group (&) do not fit the regression
line.
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